Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results.

Researchers found that a medication called canagliflozin can greatly reduce the risk of kidney failure in people with type 2 ...

Dr. Scott Summers, the lead researcher, said they were amazed by the results. By turning off ceramides, they completely ...

The results of a late-stage drug trial released Thursday are raising hopes that type 1 diabetes patients with chronic kidney ...

These drugs promise faster results with fewer side effects, and in some cases, reversal or slows the disease progression.

Researchers uncovered how fatty molecules called ceramides trigger acute kidney injury by damaging the mitochondria that ...

If the drug works in people, it could prevent kidney injury in high-risk populations, or potentially even treat other ...

NEW YORK, Nov 15: Researchers say recent advances in chronic kidney disease (CKD) treatments are showing unprecedented ...

The drug finerenone has a positive effect on patients with type 1 diabetes and chronic kidney disease. The drug reduces the ...

In a landmark move, the US Food and Drug Administration (FDA) has given biotech company eGenesis the go-ahead to conduct a broader human trial in pig-to-human kidney transplants, marking a significant ...

Arch acquires a new CKD platform that has the potential to produce next-generation CKD drugs for the pharmaceutical industry Based on a novel mechanism of action involving IL-32 and directly ...

Scientists have reversed acute kidney injury in mice by genetically altering ceramide processing, preventing damage to ...